More on ORKA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-10.9% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Oruka Therapeutics (NQ:ORKA)
Delayed: 92.70 +9.66 (11.63%)
Prev. Close $83.04  
Open$81.67 
52 Wk High$ 
52 Wk Low$ 
Day High$93.00 
Day Low$80.73 
P/E N/A  
EPS$ 
Volume2,804,761 

Friends, Peers and Foes (?): HALO, ABBV, AMGN, ANAB, BMY (more...)

Jul 15, 2026 07:36 PM Form 4 Oruka Therapeutics, Inc. For: Jul 15 Filed by: Goncalves Joana
Jul 15, 2026 04:31 PM Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
Jul 13, 2026 05:09 PM Form 4 Oruka Therapeutics, Inc. For: Jul 13 Filed by: Agarwal Arjun
Jul 13, 2026 04:36 PM Form 144 Oruka Therapeutics, Inc. Filed by: Agarwal Arjun
Jul 1, 2026 09:31 PM Form 144 Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
Jul 1, 2026 09:30 PM Form 4 Oruka Therapeutics, Inc. For: Jul 01 Filed by: Fairmount Healthcare Fund II L.P.
Jul 1, 2026 09:30 PM Form SCHEDULE 13D/A Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
Jul 1, 2026 07:58 PM Form 4 Oruka Therapeutics, Inc. For: Jul 01 Filed by: Sandler Laura Lee
Jul 1, 2026 09:21 AM Oruka Therapeutics (ORKA) PT Raised to $130 at UBS as Stock Undervalued
Jun 23, 2026 06:49 AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
View All Articles

Entities mentioned with ORKA

View All Entities